Penetration of Clindamycin and Its Metabolite N -Demethylclindamycin into Cerebrospinal Fluid following Intravenous Infusion of Clindamycin Phosphate in Patients with AIDS
Authors:
- 1 November 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (11) , 3014-3017
Abstract
Clindamycin, which is usually used in combination with pyrimethamine, has been proven effective in the treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients. However, it is not known if clindamycin achieves inhibitory concentrations at the site of infection. Also, it has been hypothesized that the activity of clindamycin against Toxoplasma gondii may be due, at least in part, to a metabolite. We evaluated the penetration of clindamycin and its major metabolite, N -demethylclindamycin (NDC), into cerebrospinal fluid (CSF) of AIDS patients undergoing lumbar puncture for diagnostic purposes. A single, 1,200-mg dose of clindamycin was administered as a 45-min intravenous infusion beginning at 1.5 or 2.5 h before CSF sampling. The concentrations of clindamycin in CSF ranged from 0.091 to 0.429 mg/liter at 1.5 h and from 0.120 to 0.283 mg/liter at 2.5 h following the beginning of the infusion. The concentrations of clindamycin in CSF were well above the 50% inhibitory concentration of 0.001 mg/liter and the parasiticidal concentration of 0.006 mg/liter. NDC was undetectable both in plasma and in CSF. Our study provides a pharmacokinetic rationale for the clinical efficacy of clindamycin in the treatment of cerebral toxoplasmosis.Keywords
This publication has 15 references indexed in Scilit:
- Toxoplasmic encephalitis in HIV-infected persons: risk factors and trendsAIDS, 1996
- Treatment of Toxoplasmic Encephalitis in Patients with AIDSAnnals of Internal Medicine, 1992
- Some aspects of the epidemiology of toxoplasmosis and pneumocystosis in AIDS in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Gastropathy and Ketoconazole Malabsorption in the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1988
- Determination of clindamycin in plasma or serum by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Toxoplasmic EncephalitisThe Journal of Infectious Diseases, 1988
- In Vitro Assessment of Antimicrobial Agents Against Toxoplasma gondiiThe Journal of Infectious Diseases, 1988
- Clindamycin in a murine model of toxoplasmic encephalitisAntimicrobial Agents and Chemotherapy, 1987
- Membrane transport of clindamycin in alveolar macrophagesAntimicrobial Agents and Chemotherapy, 1982
- Absorption, Excretion and Half-Life of Clinimycin in Normal Adult MalesThe American Journal of the Medical Sciences, 1968